Strategies for Optimizing Bacillus Calmette-Guérin
Keywords: Bacillus Calmette-Guerin; Superficial bladder cancer; Non-muscle invasive bladder cancer; Bacillus Calmette-Guérin;
مقالات ISI Bacillus Calmette-Guerin (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance
Keywords: Bacillus Calmette-Guerin; Non-muscle invasive bladder cancer; Randomized Controlled Trial; Immunotherapy; Bacillus Calmette-Guerin; Adjuvant treatment; Urinary bladder; Maintenance therapy
Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer
Keywords: Bacillus Calmette-Guerin; apaziquone; urinary bladder neoplasms; drug therapy; administration; intravesical; AE; adverse event; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral resection of bla
Economic and Humanistic Consequences of Preventable Bladder Tumor Recurrences in Nonmuscle Invasive Bladder Cancer Cases
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; administration, intravesical; mitomycin; economics, pharmaceutical; quality-adjusted life years; BCG; bacillus Calmette-Guérin; IVIC; intravesical instillation of chemotherapy; MMC; mitomycin C; NMIBC; nonmuscle invasive bladde
Impact of Smoking on Outcomes of Patients with a History of Recurrent Nonmuscle Invasive Bladder Cancer
Keywords: Bacillus Calmette-Guerin; urinary bladder; urothelium; carcinoma; smoking; survival; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CPD; cigarettes per day; NMIBC; nonmuscle invasive bladder cancer; TURB; transurethral resection of bladder; UCB; urothelial carcinoma of bl
Research ReportModulatory effects of acupuncture on murine depression-like behavior following chronic systemic inflammation
Keywords: Bacillus Calmette-Guerin; 3-OHKYN; 3-hydroxykynurenine; 5-HIAA; 5-hydroxyindole-3-acetic acid; 5-HT; 5-hydroxytryptamine, serotonin; ANOVA; analysis of variance; BCG; Bacillus Calmette-Guérin; BH4; tetrahydrobiopterin; CFU; colony forming unit; CNS; central nerve system; DA; dopa
Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease
Keywords: Bacillus Calmette-Guerin; CD; Crohn's disease; PPD; purified protein derivative; TPN; total parenteral nutrition; CDAI; CD activity index; CR-70; decrease in CDAI score from Baseline â¥Â 70; CR-100; decrease in CDAI score from Baseline â¥Â 100; eow; every other week; 6-MP; 6-m
Usefulness of the Spanish Urological Club for Oncological Treatment Scoring Model to Predict Nonmuscle Invasive Bladder Cancer Recurrence in Patients Treated With Intravesical Bacillus Calmette-Guérin Plus Interferon-α
Keywords: Bacillus Calmette-Guerin; urinary bladder; urinary bladder neoplasms; BCG vaccine; interferon alfa-2b; prognosis; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CUETO; Spanish Urological Club for Oncological Treatment; EORTC; European Organization for Research and Treatme
Frequency of Tumor Recurrence: A Strong Predictor of Stage Progression in Initially Diagnosed Nonmuscle Invasive Bladder Cancer
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; disease progression; recurrence; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; FTR; frequency of tumor recurrence; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral resection of bladder tumor;
The influence of high-grade and low-grade histological sub-classification of G2 pT1 transitional cell cancer of bladder on tumour recurrence and progression rates—5-Year retrospective analysis
Keywords: Bacillus Calmette-Guerin; Transitional cell cancer; Bladder; Bacillus Calmette-Guerin; Histological grade
Association of death receptor 4, Caspase 3 and 5 gene polymorphism with increased risk to bladder cancer in North Indians
Keywords: Bacillus Calmette-Guerin; Apoptosis; Bacillus Calmette-Guerin; Bladder cancer; Haplotype; Polymorphism
NRAMP1 and hGPX1 Gene Polymorphism and Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer
Keywords: Bacillus Calmette-Guerin; Bacillus Calmette-Guérin; Bladder cancer; Gene polymorphism;
Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guérin and with Bacillus Calmette-Guérin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial
Keywords: Bacillus Calmette-Guerin; Bacillus Calmette-Guérin; Carcinoma in situ; Intravesical therapy; Mitomycin C; Non-muscle-invasive bladder cancer; Randomized clinical trial; Urinary bladder;
MAp19, the alternative splice product of the MASP2 gene
Keywords: Bacillus Calmette-Guerin; MBL; mannan-binding lectin; MASP; MBL-associated serine protease; MAp; MBL-associated protein; pAb; polyclonal antibody; MBS; m-maleimidobenzoyl-N-hydroxysuccinimid; DVS; divinylsulfone; PPD; purified protein derivative; HRP; horseradish peroxidase; KLH;
The role of the China Experts Advisory Committee on Immunization Program
Keywords: Bacillus Calmette-Guerin; AFP; Acute Flaccid Paralysis; BCG; Bacillus Calmette-Guérin; CCDC; Chinese Center for Disease Control and Prevention; DTP; diphtheria, tetanus and pertussis; EACIP; Experts Advisory Committee on Immunization Program; EPI; Expanded Program on Immunization
Exposition d’une cohorte de nouveau-nés à une tuberculose bacillifère dans un service de néonatalogie
Keywords: Bacillus Calmette-Guerin; Antibiothérapie néonatale; BCG; TuberculoseNeonatal antibiotic treatment; Bacillus Calmette-Guerin; Tuberculosis
The Role of Tumor-Free Status in Repeat Resection Before Intravesical Bacillus Calmette-Guerin for High Grade Ta, T1 and CIS Bladder Cancer
Keywords: Bacillus Calmette-Guerin; urinary bladder; urinary bladder neoplasms; Mycobacterium bovis; neoplasm recurrence; local; reoperation; BCG; bacillus Calmette-Guerin; EAU; European Association of Urology; FICBT; First International Consultation on Bladder Tumors; RTG; residual tumor g
Challenging the EAU Guidelines on Non-Muscle-Invasive Bladder Cancer (NMIBC): Single Instillation of Chemotherapy After Transurethral Resection of NMIBC and Chemotherapy Versus Bacillus Calmette-Guérin in Treatment of Intermediate-Risk Tumours
Keywords: Bacillus Calmette-Guerin; Non-muscle-invasive bladder cancer; Treatment; EAU guidelines; Bacillus Calmette-Guérin; Intravesical chemotherapy; Transurethral resection of the bladder tumour;
Nonprimary pT1 Nonmuscle Invasive Bladder Cancer Treated With Bacillus Calmette-Guerin is Associated With Higher Risk of Progression Compared to Primary T1 Tumors
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; disease progression; recurrence; mortality; BCG vaccine; BCG; bacillus Calmette-Guerin; CIS; carcinoma in situ; DSS; disease specific survival; NMI-BC; nonmuscle invasive bladder cancer; PFS; progression-free survival; RFS; recu
Significance of Distal Ureteral Margin at Radical Cystectomy for Urothelial Carcinoma
Keywords: Bacillus Calmette-Guerin; ureter; urinary diversion; urothelium; carcinoma; neoplasm recurrence; BCG; bacillus Calmette-Guerin; UC; urothelial carcinoma;
IL-8 −251 T > A Polymorphism Is Associated with Bladder Cancer Susceptibility and Outcome after BCG Immunotherapy in a Northern Indian Cohort
Keywords: Bacillus Calmette-Guerin; Carcinoma of bladder; bacillus Calmette-Guerin; Recurrence; Interleukin-8; Haplotype; NF-κB
Myopodin Methylation is Associated With Clinical Outcome in Patients With T1G3 Bladder Cancer
Keywords: Bacillus Calmette-Guerin; urinary bladder; urinary bladder neoplasms; Mycobacterium bovis; SYNPO2 protein; human; methylation; BCG; bacillus Calmette-Guerin; CIS; carcinoma in situ; MMC; mitomycin C; NED; no evidence of disease; TUR; transurethral resection;
Marker Lesion Experiments in Bladder Cancer-What Have We Learned?
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; ethics; research; safety; patient selection; antineoplastic agents; BCG; bacillus Calmette-Guerin; CR; complete response; IL; interleukin; MMC; mitomycin-C; TNF-α; tumor necrosis factor-α; TURBT; transurethral resection of bla
Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; 5-aminolevulinic acid hexyl ester; fluorescence; cystoscopy; recurrence; AE; adverse event; ALA; aminolevulinic acid; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; HAL; hexaminolevulinate; ITT; intent to treat; PPS; pe
Research ArticleSoluble TNF, but not membrane TNF, is critical in LPS-induced hepatitis
Keywords: Bacillus Calmette-Guerin; Liver injury; BCG liver granulomas; Soluble TNF; Membrane TNF; TNF; tumor necrosis factor; BCG; Bacillus Calmette-Guérin; solTNF; soluble TNF; memTNF; membrane TNF; TNF KI; TNF knock-in; sTNFR1-Fc; soluble TNF receptor 1 fusion protein; tg; transgenic; i
Long-term Efficacy of Maintenance Bacillus Calmette-Guérin versus Maintenance Mitomycin C Instillation Therapy in Frequently Recurrent TaT1 Tumours without Carcinoma In Situ: A Subgroup Analysis of the Prospective, Randomised FinnBladder I Study with a 20
Keywords: Bacillus Calmette-Guerin; Bacillus Calmette-Guerin; Instillation therapy; Long-term efficacy; Mitomycin C; Non-muscle invasive bladder cancer; Recurrent
Long-Term Outcome of Simultaneous Transurethral Resection of Bladder Tumor and Prostate in Patients With Nonmuscle Invasive Bladder Tumor and Bladder Outlet Obstruction
Keywords: Bacillus Calmette-Guerin; urinary bladder; prostate; urinary bladder neoplasms; transurethral resection of prostate; neoplasm recurrence; local; BCG; bacillus Calmette-Guerin; BOO; bladder outlet obstruction; BPH; benign prostate hyperplasia; CIS; carcinoma in situ; MMC; mitomycin
Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised Patients
Keywords: Bacillus Calmette-Guerin; BCG; bacillus Calmette-Guérin; HM; hematologic malignancy; IFN; interferon; IGRA; interferon-γ release assay; LTBI; latent tuberculosis infection; LTC; liver transplantation candidate; MTB; Mycobacterium tuberculosis; QFT-IT; QuantiFERON-TB Gold In-Tube
An Analysis of the Effect of Statin Use on the Efficacy of Bacillus Calmette-Guerin Treatment for Transitional Cell Carcinoma of the Bladder
Keywords: Bacillus Calmette-Guerin; carcinoma; transitional cell; mycobacterium bovis; immunotherapy; BCG; bacillus Calmette-Guerin; GTP; guanosine triphosphate; HMG-CoA; 3-hydroxy-3-methylglutaryl coenzyme A; TCC; transitional cell carcinoma; TUR; transurethral resection;
Prevention of Recurrence With Epirubicin and Lactobacillus Casei After Transurethral Resection of Bladder Cancer
Keywords: Bacillus Calmette-Guerin; bladder; bladder neoplasms; neoplasm recurrence, local; epirubicin; Lactobacillus casei; BCG; bacillus Calmette-Guerin; EPI-ADM; epirubicin; LC; Lactobacillus casei; TUR; transurethral resection;
Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; mycobacterium bovis; administration; intravesical; chemotherapy; adjuvant; epirubicin; BCG; bacillus Calmette-Guerin; CIS; carcinoma in situ; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral resection of bladder tu
A Single Instillation of Epirubicin After Transurethral Resection of Bladder Tumors Prevents Only Small Recurrences
Keywords: Bacillus Calmette-Guerin; bladder; bladder neoplasms; neoplasm recurrence; local; administration; intravesical; epirubicin; BCG; bacillus Calmette-Guerin; TUR; transurethral resection;
Active Specific Immunotherapy Phase III Trials for Malignant Melanoma: Systematic Analysis and Critical Appraisal
Keywords: Bacillus Calmette-Guerin; ASI; active specific immunotherapy; BCG; bacillus Calmette-Guérin; DFS; disease-free survival; DTIC; dacarbazine; GM2; ganglioside; GMK; GM2 keyhole limpet hemocyanin; HR; hazard ratio; OS; overall survival; TAA; tumor-associated antigen; VMCL; vaccinia
Poliartritis secundaria a instilaciones intravesicales de BCG, a propósito de un casoPolyarthritis secondary to intravesical bcg instillation, a case report
Keywords: Bacillus Calmette-Guerin; Artritis; poliartritis; Cáncer de vejiga superficial; Bacilo Calmette-Guérin; Inmunoterapia; Arthritis; Polyarthritis; Superficial bladder cancer; Bacillus Calmette-Guérin; Immunotherapy;
Did Patients With Interstitial Cystitis Who Failed to Respond to Initial Treatment With Bacillus Calmette-Guerin or Placebo in a Randomized Clinical Trial Benefit From a Second Course of Open Label Bacillus Calmette-Guerin?
Keywords: Bacillus Calmette-Guerin; bladder; Mycobacterium bovis; cystitis; interstitial; quality of life; pain; BCG; bacillus Calmette-Guerin; GRA; global response assessment; IC; interstitial cystitis; ICCTG; IC Clinical Trials Group; ICPI; O'Leary-Sant IC Problem Index; ICSI; O'Leary
Patterns of Recurrence and Outcomes Following Induction Bacillus Calmette-Guerin for High Risk Ta, T1 Bladder Cancer
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; cystectomy; administration; intravesical; mycobacterium bovis; immunotherapy; BCG; bacillus Calmette-Guerin; CIS; carcinoma in situ; EORTC; European Organization for Research and Treatment of Cancer; NED; no evidence of disease;
Imperative Indications for Conservative Management of Upper Tract Transitional Cell Carcinoma
Keywords: Bacillus Calmette-Guerin; ureter; carcinoma; transitional cell; endoscopy; ureteral neoplasms; ureteroscopy; ASA; American Society of Anesthesiologists; BCG; bacillus Calmette-Guerin; CT; computerized tomography; IVP; excretory urogram; TCC; transitional cell carcinoma;
A Randomized Trial of Radical Radiotherapy for the Management of pT1G3 NXM0 Transitional Cell Carcinoma of the Bladder
Keywords: Bacillus Calmette-Guerin; urinary bladder neoplasms; randomized controlled trials; radiotherapy; BCG; bacillus Calmette-Guerin; CIS; carcinoma in situ; IDMC; Independent Data Monitoring Committee; MMC; mitomycin C; MRC; Medical Research Council; QLQ; quality of life questionnaire;
A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomyci
Keywords: Bacillus Calmette-Guerin; Bladder cancer; Bacillus Calmette-Guerin; Mitomycin C; Adjuvant therapy
Risk Factors for Upper Tract Recurrence in Patients Undergoing Long-Term Surveillance for Stage Ta Bladder Cancer
Keywords: Bacillus Calmette-Guerin; bladder neoplasms; urologic neoplasms; risk factors; recurrence; ANED; alive no evidence of disease; BCG; bacillus Calmette-Guerin; BT; bladder tumor; DNED; dead no evidence of disease; DOD; dead of disease; IVP; excretory urogram; NED; no evidence of dis
Bilateral Metachronous Ureteral and Renal Pelvic Carcinomas: Incidence, Clinical Presentation, Histopathology, Treatment and Outcome
Keywords: Bacillus Calmette-Guerin; ureteral neoplasms; prognosis; urography; BCG; bacillus Calmette-Guerin; UUTT; urothelial upper tract tumor; WHO; World Health Organization;
Chemoprevention for Bladder Cancer
Keywords: Bacillus Calmette-Guerin; bladder; bladder neoplasms; carcinoma; transitional cell; chemoprevention; vitamins; ATBC; α-tocopherol β-carotene; BBN; N-butyl-N-(4-hydroxybutyl)nitrosamine; BC; bladder cancer; BCG; bacillus Calmette-Guerin; COX; cyclooxygenase; CPS; Cancer Preventio
BCG Dose Reduction by Decreasing the Instillation Frequency: Effects on Local Th1/Th2 Cytokine Responses in a Mouse Model
Keywords: Bacillus Calmette-Guerin; Bacillus Calmette-Guérin; Immunotherapy; Cytokines;
Ten-month-old boy with persistent fever and a chest mass
Keywords: Bacillus Calmette-Guerin; BCG; Bacillus Calmette-Guerin; BMT; Bone marrow transplantation; CGD; Chronic granulomatous disease; NBT; Nitroblue tetrazolium test; PM; Patient-months; PPD; Tuberculin-purified protein derivative; ROS; Reactive oxygen species; TMP-SMX; Trimethoprim-sulf
EAU Guidelines on the Diagnosis and Treatment of Urothelial Carcinoma in Situ
Keywords: Bacillus Calmette-Guerin; Bladder cancer; Carcinoma in situ; Bacillus Calmette-Guerin; Chemotherapy; Diagnosis; Treatment; Follow up;
Role of CD8+ T lymphocytes in control of Mycobacterium tuberculosis infection
Keywords: Bacillus Calmette-Guerin; Tuberculosis; CD8-positive T-lymphocytes; Antigen presentation; Immunologic surveillance; BCG; Bacillus Calmette-Guerin; β2 m; beta(2)-microglobulin; DC; dendritic cell; ER; endoplasmic reticulum; HLA; human leukocyte antigen; IFNγ; interferon-gamma; L
Development of an Adult-Like Cell-Mediated Immune Response in Calves After Early Vaccination with Mycobacterium bovis bacillus Calmette-Guérin*
Keywords: Bacillus Calmette-Guerin; neonatal vaccination; adaptive immunity; Mycobacterium bovis BCG; calf; BCG; bacillus Calmette-Guérin; FBS; fetal bovine serum; PBMC; peripheral blood mononuclear cells; PBST; PBS with Tween 80; PBST-g; PBST with gelatin; PPD; purified protein derivative
The influence of photodynamic therapy on the immune response
Keywords: Bacillus Calmette-Guerin; 8-MOP; 8-methoxypsoralen; BCG; Bacillus Calmette-Guerin; ALA; 5-aminolevulinic acid; CD; cluster of differentiation; CHS; contact hypersensitivity; DBPMAF; Vitamin D3-binding protein-derived macrophage-activating factor; DC; dendritic cells; EAE; experime